Alnylam Pharma (ALNY) Tops Q2 EPS by 16c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq end lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Alnylam Pharmaceuticals (ALNY) PT Raised to $210 at B.Riley/FBR
August 3, 2018 9:17 AM EDTB.Riley/FBR raised its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $210.00 (from $200.00) while maintaining a Buy rating.
... MoreAlnylam Pharmaceuticals (ALNY) PT Lowered to $99 at Morgan Stanley
August 3, 2018 7:42 AM EDTMorgan Stanley lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $99.00 (from $107.00) while maintaining a Equalweight rating.
... More